Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: June 28, 2022

Indoco Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for INDOCO, and what generic and branded alternatives to INDOCO drugs are available?

INDOCO has fifteen approved drugs.

There is one tentative approval on INDOCO drugs.

Summary for Indoco

US Patents:	0
Tradenames:	14
Ingredients:	14
NDAs:	15

Drugs and US Patents for Indoco

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Indoco	OLANZAPINE	olanzapine	TABLET;ORAL	206155-004	Jul 31, 2020	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Indoco	OLANZAPINE	olanzapine	TABLET;ORAL	206155-006	Jul 31, 2020	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Indoco	LACOSAMIDE	lacosamide	TABLET;ORAL	208308-004	Mar 17, 2022	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Indoco	NEOSTIGMINE METHYLSULFATE	neostigmine methylsulfate	SOLUTION;INTRAVENOUS	210652-001	Oct 1, 2021	AP	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

Merck

Johnson and Johnson

Express Scripts

Colorcon

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.